Example: Heart Attack

Search clinical trials for: Modulation of FiO2

Total 10000 results

NCT01917214

Completed

A Retrospective Real World Analysis Of Sutent In Patients With Metastatic Renal Cell Carcinoma In Community And Academic Centers To Assess The Impact Of Dose Variation On Duration Of Response And Overall Survival

Metastatic Renal Cell Carcinoma
NCT00399152

Completed

Perifosine + Sunitinib Malate for Patients With Advanced Cancers

Renal Cancer | GIST
NCT00748358

Completed

An Open-label Phase II Study With SUTENT in Patients Suffering From Hormone Refractory Prostate Cancer (PROSUT)

Prostatic Neoplasms | Neoplasms, Hormone-Dependent | Survival Rate | Disease-Free Survival | Tumor Markers, Biological
NCT00678119

Completed

Study Testing the Biologic Activity and Safety of a Immunotherapeutic in Patients With Newly Diagnosed Advanced Stage Kidney Cancer in Combination With a Marketed Renal Cell Carcinoma Treatment

Renal Cell Carcinoma
NCT01073644

Terminated

Post Marketing Surveillance On The Safety And Tolerability Of Sunitinib Malate (Sutent) For Filipino Patients

Metastatic Renal Cell Carcinoma
NCT00620347

Completed

Sunitinib as a Second-line Treatment for Patients With Recurrent Small Cell Lung Cancer

Lung Cancer
NCT00338884

Completed

Safety And Effectiveness Of Daily Dosing With 37.5 mg Sunitinib Malate In Patients With Advanced Kidney Cancer

Carcinoma, Renal Cell
NCT00550810

Unknown

Sutent Maintenance After Response to Taxotere (SMART)

Prostate Cancer | Hormone Refractory
NCT00143715

Completed

Oral Vitamin K for Warfarin Associated Coagulopathy

Thrombosis | Bleeding | Coagulation
NCT01219751

Unknown

Trial Of Sunitinib In Advanced Non-Clear Cell Type Renal Cell Carcinoma

Metastatic Renal Cell Carcinoma
NCT00372775

Completed

Study Tests The Safety And Effectiveness Of SU011248 In Patients With Non-Small Cell Lung Cancer Having Brain Metastases

Non-Small Cell Lung Cancer
NCT00308503

Completed

Efficacy and Safety of Eplivanserin 5mg/Day on Sleep Maintenance Insomnia (EPOCH)

Insomnia | Sleep Initiation and Maintenance Disorders
NCT00428597

Terminated

A Study Of Sunitinib Compared To Placebo For Patients With Advanced Pancreatic Islet Cell Tumors

Carcinoma, Islet Cell | Carcinoma, Pancreas
NCT00006247

Terminated

SU5416 in Treating Children With Recurrent or Progressive Brain Tumors

Brain and Central Nervous System Tumors
NCT00371553

Completed

Phase-II Study of SU011248 (Sunitinib)in Male Patients With Relapsed or Cisplatin-Refractory Germ Cell Cancer

Relapsed or Cisplatin-Refractory Germ Cell Cancer
NCT00005931

Completed

SU5416 in Patients With AIDS-Related Kaposi's Sarcoma Who Have Not Responded to Treatment

HIV Infections | Sarcoma, Kaposi
NCT05750134

Completed

Endoscopic Sleeve Gastroplasty for Moderate Obesity (PLICATURE)

Obesity
NCT00322387

Completed

Mobilization of Stem Cells With Plerixafor, Chemotherapy and G-CSF in Multiple Myeloma or Non-Hodgkin's Lymphoma Patients

Lymphoma, Non-Hodgkin | Multiple Myeloma
NCT05500443

Active, not recruiting

The DANish COronary DEcalcification (DANCODE) Trial (DANCODE)

Coronary Artery Disease
NCT00150969

Completed

Vitamin K Supplementation in Post-Menopausal Osteopenia

Post-Menopausal Osteoporosis | Post-Menopausal Osteopenia
NCT01319188

Terminated

Ranibizumab and the Risk of Arterial Thromboembolic Events (RATE)

Coronary Artery Disease | Cerebrovascular Disorders | Age-related Macular Degeneration
NCT07098780

Recruiting

Role of Tranexamic Acid in Reducing Hemorrhagic Events in Bariatric Surgery

Hemorrhage | Obesity, Morbid | Bariatric Surgery
NCT06982924

Not yet recruiting

A Clinical Study on the Efficacy and Safety of the Combination of Limertinib and Bevacizumab Versus Limertinib as First-line Treatment for NSCLC. (LIBRA)

PD-L1 Positive | EGFR Mutation Positive Advanced Non Small Cell Lung Cancer
NCT06868511

Recruiting

Neuronavigation-assisted Stereotactic Puncture With Tenecteplase for Acute Intracerebral Hemorrhage (NAS-TNK)

Deep Intracerebral Hemorrhage (ICH)
NCT06770829

Not yet recruiting

Implementation of a Preventive Diabetic Foot Care Program for Patients at Risk of Diabetic Foot

Diabetic Foot Ulcer | Type 2 Diabetes Mellitus With Complication
NCT06188052

Recruiting

Efficacy of Topical Versus Intravenous Tranexamic Acid in Controlling Blood Loss

To Calculate Total Blood Loss Immediately Postoperative
NCT05957822

Recruiting

Goal-directed vs Preemptive Tranexamic Acid Administration in Non-cardiac Surgery

Prostate Cancer | Hepatic Cancer | Spine Fusion | Arthritis Knee | Arthritis of Hip
NCT05894824

Recruiting

T-Dxd in Combination With Ramucirumab as HER2 Low Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Gastric Cancer | Gastroesophageal Junction (GEJ) Cancer
NCT05821361

Not yet recruiting

HAIC Combined With Cadonilimab and Bevacizumab as First-line Therapy in Unresectable Hepatocellular Carcinoma

Unrescetable Hepatocellular Carcinoma
NCT05819060

Not yet recruiting

The Efficacy and Safety of The Fuzuloparib Combination With Bevacizumab

Recurrent Ovarian Cancer
NCT05806346

Recruiting

Goal-directed vs. Empirical Tranexamic Acid Administrationin Cardiovascular Surgery

Heart Diseases | Vascular Diseases | Fibrinolysis; Hemorrhage | Transfusion Related Complication | Coagulation Disorder, Blood
NCT05385185

Recruiting

Clinical Observation of ICI Combined With Recombinant Human Endostatin on Leptomeningeal Metastasis of Lung Cancer

Leptomeningeal Metastasis | Immune Checkpoint Inhibitor | Endostatin
NCT04796025

Recruiting

TACE Combined With Sintilimab Plus Bevacizumab Biosimilar in Hepatocellular Carcinoma (BCLC-C Stage ): a Prospective Single-arm Phase II Clinical Study (T-Double)

Hepatocellular Carcinoma
NCT02820857

Completed

Assessment of the Efficacy of Bevacizumab in Combination With Folfiri as Second-line Treatment in Patients Suffering From an Advanced Inoperable Poorly Differentiated Neuroendocrine Carcinoma of an Unknown or Gastroentero-pancreatic Primary Cancer (BEVANEC)

Neuroendocrine Carcinomas
NCT01295944

Completed

Carboplatin and Bevacizumab for Recurrent Ependymoma

Ependymoma | Anaplastic Ependymoma
NCT07096713

Completed

Brolucizumab Versus Aflibercept on Visual and Anatomical Outcomes in Diabetic Macular Edema (Anti-VEGF)

Anti-VEGF Therapy
NCT03187405

Terminated

Intraventricular Fibrinolysis for Aneurysmal Subarachnoid Hemorrhage. (FIVHeMA)

Subarachnoid Hemorrhage
NCT06983704

Completed

Assessing Combined Bevacizumab-Mitomycin C Use During Ahmed Valve Revision in Recurrent Pediatric Glaucoma (MMC glaucoma)

Pediatric Glaucoma
NCT05419505

Completed

Study of Different Interventions to Reduce Bruising Following CCH-Aaes Treatment for Cellulite of the Buttocks (APHRODITE)

Cellulite | Edematous Fibrosclerotic Panniculopathy
NCT05752461

Completed

SHR-2004 for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty

Prevention of Venous Thromboembolism After Knee Arthroplasty
NCT04047472

Completed

Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Chinese Patients With Neovascular Age-Related Macular Degeneration

Neovascular Age-Related Macular Degeneration
NCT06618820

Enrolling by invitation

Extended Oral Tranexamic Acid After Total Knee Arthroplasty

Pain, Postoperative | Osteo Arthritis Knee
NCT05211804

Completed

Mechanisms of Retinal Revascularization and Clinical Indicators of Neovascular AMD Relapse

Wet Macular Degeneration
NCT04559880

Completed

Tranexamic Acid to Prevent Bleeding After Endoscopic Resection of Large Colorectal Polyps: A Pilot Project

Polyp, Colorectal
NCT05321199

Completed

Tranexamic Acid During Telescoping Nail Application In Osteogenesis Imperfecta

Osteogenesis Imperfecta
NCT02305238

Completed

Japanese Treat and Extend Study of Aflibercept in Neovascular Age-related Macular Degeneration (ALTAIR)

Wet Macular Degeneration
NCT01783925

Completed

Eylea Post Marketing Surveillance(PMS)

Macular Degeneration
NCT02289924

Completed

Aflibercept (Eylea) in roUtine Clinical Practice in patientS With Wet Age-related Macular Degeneration in Italy (PERSEUS-IT)

Wet Macular Degeneration
NCT02279537

Completed

Real Life of Aflibercept In FraNce: oBservatiOnnal Study in Wet AMD (RAINBOW)

Wet Macular Degeneration
NCT02399085

Completed

Open Label Study to Evaluate the Safety and Efficacy of Lenalidomide With MOR00208 in Patients With R-R DLBCL (L-MIND)

Diffuse Large B-cell Lymphoma

Search clinical trials for: Modulation of FiO2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations